Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases.

Journal of medicinal chemistry - 26 Jan 2012

Abu Thaher Bassam, Arnsmann Martina, Totzke Frank, Ehlert Jan E, Kubbutat Michael H G, Schächtele Christoph, Zimmermann Markus O, Koch Pierre, Boeckler Frank M, Laufer Stefan A

Abstract excerpt

In the course of searching for new p38α MAP kinase inhibitors, we found that the regioisomeric switch from 3-(4-fluorophenyl)-4-(pyridin-4-yl)-1-(aryl)-1H-pyrazol-5-amine to 4-(4-fluorophenyl)-3-(pyridin-4-yl)-1-(aryl)-1H-pyrazol-5-amine led to an almost complete loss of p38α inhibition, but they...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Enzyme Assays
Share to p38 Mitogen-Activated Protein Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins B-raf

Share to Pyrazoles

Share to src-Family Kinases

Share to Stereoisomerism

Share to Structure-Activity Relationship

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 22185282
DOI: 10.1021/jm201391u

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22185282-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases.PMID 22185282Read ↗

Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors.Semantic proximity Read ↗

The mystery of titan hunter: Rationalized striking of the MAPK pathway via Newly synthesized 6-Indolylpyridone-3-Carbonitrile derivatives.Semantic proximity Read ↗

Discovery of 6-[(3 S ,4 S )-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 InhibitorSemantic proximity Read ↗

Optimization of Aminoindazole derivatives as highly selective covalent inhibitors for wild-type and mutant FGFR4.Semantic proximity Read ↗

Synthesis of N -(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and in vitro anti-glioma activitySemantic proximity Read ↗

Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity.Semantic proximity Read ↗

Discovery of Substituted 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine Derivatives as Potent and Selective FGFR Kinase InhibitorsSemantic proximity Read ↗

Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways.Semantic proximity Read ↗

N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl.Semantic proximity Read ↗

Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds.Semantic proximity Read ↗

Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancerSemantic proximity Read ↗

A Special View of What Was Almost Forgotten: p38δ MAPKSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.